1 Min Read
Jan 9 (Reuters) -
* Valeant nears deal to sell dendreon cancer business to China’s Sanpower for more than $750 million - CNBC, citing Dow Jones Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.